Olmesartan/amlodipine/hydrochlorothiazide
| Combination of | |
|---|---|
| Olmesartan | Angiotensin II antagonist |
| Amlodipine | Calcium channel blocker |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | Tribenzor, Sevikar HCT |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number |
|
| KEGG |
|
Olmesartan/amlodipine/hydrochlorothiazide, sold under the brand name Tribenzor among others, is a fixed-dose combination medication used to treat high blood pressure.[3] It contains olmesartan medoxomil, an angiotensin II receptor blocker, amlodipine, as the besilate, a calcium channel blocker, and hydrochlorothiazide, a thiazide diuretic.[3] It is taken by mouth.[3]
References
- ^ a b "AusPAR: Olmesartan medoxomil / Amlodipine (as besilate) / Hydrochlorothiazide". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 28 April 2023.
- ^ "Amlodipine / hydrochlorothiazide / olmesartan (Tribenzor) Use During Pregnancy". Drugs.com. 8 April 2020. Archived from the original on 21 October 2020. Retrieved 22 August 2020.
- ^ a b c d "Tribenzor- olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide tablet, film coated". DailyMed. 27 May 2020. Archived from the original on 7 August 2020. Retrieved 22 August 2020.
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |